New Age Alpha Advisors LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.3% in the first quarter, according to its most recent filing with the SEC. The fund owned 29,109 shares of the healthcare conglomerate's stock after selling 1,964 shares during the period. UnitedHealth Group comprises about 0.7% of New Age Alpha Advisors LLC's portfolio, making the stock its 13th largest holding. New Age Alpha Advisors LLC's holdings in UnitedHealth Group were worth $15,246,000 as of its most recent filing with the SEC.
Other hedge funds have also modified their holdings of the company. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group in the 4th quarter worth about $26,000. Bayforest Capital Ltd increased its position in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $30,000. Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $41,000. Finally, Copia Wealth Management purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $42,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Price Performance
NYSE UNH opened at $240.94 on Tuesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a 50-day simple moving average of $295.77 and a 200 day simple moving average of $412.81. The stock has a market capitalization of $218.57 billion, a PE ratio of 10.44, a P/E/G ratio of 1.50 and a beta of 0.43. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 EPS. The company's revenue was up 12.9% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 3.7%. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 38.30%.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on the company. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a report on Friday, June 20th. Piper Sandler lowered their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. TD Securities reiterated a "hold" rating and issued a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $371.67.
Check Out Our Latest Analysis on UNH
Insider Activity at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kristen Gil acquired 3,700 shares of the company's stock in a transaction dated Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director owned 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock worth $31,607,768 in the last three months. Company insiders own 0.28% of the company's stock.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.